Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.

Around half of study participants, all age 65 or younger, wouldn’t have been eligible for statins if they’d sought care 2 ...

Extra scrutiny is warranted to identify the underlying causes of chest pain in patients with nonobstructive coronary disease ...

High systolic blood pressure in adolescence is tied to a significantly higher risk of developing coronary atherosclerosis ...

November 20, 2025 | Ami Bhatt speaks with Tim Ryan about heart valve technology and the development of the Melody valve.

Ami Bhatt, Jenny Zablah, and Gareth Morgan discuss new advanced imaging approaches for treating congenital heart disease.

The UK Biobank study suggests depression and inflammation may mediate some of the association, but clinical trials are needed ...

Some question if patients want this information, but others say this tool can put risk into context and prompt lifestyle ...

TAVR product Hydra’s 5-year follow-up results from the pivotal Hydra CE Study were presented by Dr. Vilhelmas Bajoras at PCR London Valves 2025. The long-term data reaffirm Hydra’s durable valve ...

The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.

EchoPrime was trained on more than 12 million videos; it’s now being tested clinically, with more data expected next year.